StockData
BeOne Medicines Ltd. logo

BeOne Medicines Ltd.

ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$361.27−9.06 (-2.45%)

Close on Nov 2, 2026Market cap $41.08BP/E 64.6Yield –

BeOne Medicines Gross Intangibles — Licensing Agreements by Year

Gross Intangibles — Licensing Agreements ($M) ($M)

BeOne Medicines Gross Intangibles — Licensing Agreements: $9M in FY2025, unchanged from a year earlier. That is the highest of the 9 years on record here.

Latest, FY2025
9
Period ended Dec 31, 2025
Change on a year earlier
0.0%
9 in FY2024
History
9 years
Since FY2017
Sources
9
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-Q (filed 2026-08-05) ↗

Reported in Form 10-Q / 10-K Intangible Assets Note (XBRL).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedGross Intangibles — Licensing Agreements ($M) ($M)Year on yearSource
FY2025Dec 31, 202590.0%Form 10-Q (filed 2026-08-05) ↗
FY2024Dec 31, 202490.0%Form 10-Q (filed 2025-11-06) ↗
FY2023Dec 31, 20239+1,025.0%Form 10-Q (filed 2024-11-12) ↗
FY2022Dec 31, 20220.800.0%Form 10-Q (filed 2023-11-09) ↗
FY2021Dec 31, 20210.800.0%Form 10-K (filed 2023-02-27) ↗
FY2020Dec 31, 20200.800.0%Form 10-K (filed 2022-02-28) ↗
FY2019Dec 31, 20190.800.0%Form 10-K (filed 2021-02-25) ↗
FY2018Dec 31, 20180.80–Form 10-K (filed 2020-03-02) ↗
FY2017Dec 31, 20170–Form 10-K (filed 2019-02-28) ↗

Cite this data

StockData. (2026). BeOne Medicines Gross Intangibles — Licensing Agreements ($M), annual FY2017–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/intang-gross-lic

See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.